Pharmacy Valuation and Goodwill
How community pharmacies are actually priced, and what drives the goodwill.
Community pharmacies are valued on a multiple of adjusted EBITDA and on pence-per-item benchmarks. Goodwill dominates the price because the value is driven by the NHS contract and prescription volume, not the shop fittings or the retail stock. We explain the method transparently, help buyers and sellers understand what the numbers mean, and provide valuation support for transactions, disputes, and planning purposes. We stay strictly method-level: we do not assert a specific multiple without a cited market source, because an invented number here is the most damaging thing we could give a buyer or seller. We work from your own figures, for buyers and sellers anywhere in England.
Pharmacy Valuation and Goodwill
The challenges clients face.
Understanding goodwill dominance in pharmacy pricing
Goodwill dominates pharmacy pricing. It reflects the NHS contract, the item volume, the location, and the competitive position, not the shop fitting or the till. So when you buy a pharmacy's business, the goodwill cost is the part of the price left once the stock, fixtures and equipment are valued at fair value, and you record it because the accounts have to show what your money bought: it goes on the balance sheet as an intangible asset and is written off (amortised) over its useful life. Buyers and sellers who benchmark a pharmacy against normal retail business multiples start from the wrong premise.
Adjusting EBITDA for a pharmacy: what needs normalising
Raw EBITDA in a pharmacy needs adjustment for owner remuneration (what the owner pays themselves versus a market-rate employed pharmacist), one-off costs, and the quarter-to-quarter swings in margin as DHSC resets Category M prices. An unadjusted figure will overstate or understate the true earnings capacity of the business. If you're selling, the same adjustments go into the sale-ready accounts a buyer reads.
Pence-per-item benchmarks need a cited market source
Pence-per-item benchmarks are a real pricing yardstick used by specialist pharmacy brokers, but they move with market conditions and with the contract profile of the pharmacy. We describe the method, and the purchase affordability calculator works from your own price, profit and loan figures, but we do not assert a specific benchmark without a cited market source. An invented figure here can lead a buyer to overpay or a seller to accept too little.
Goodwill and its tax consequences on a company purchase
Where the pharmacy is acquired through a company, corporation tax relief on the purchased goodwill is restricted: it needs qualifying IP assets bought with the business, and then runs at a fixed 6.5% a year on goodwill up to six times the IP's cost (CTA 2009 Part 8). A seller who owns the pharmacy personally pays CGT on the goodwill gain, with BADR potentially available at 18% for 2026/27 on qualifying disposals up to the £1m lifetime limit, which is due to fall to £500,000 from 6 April 2027 (announced at Budget 2026, not yet law). Where a company sells the business, the company pays corporation tax on its gain instead. The valuation directly sets the gain on which the tax is calculated.
Pharmacy Valuation and Goodwill
How we help.
Method-transparent valuation guidance for buyers and sellers
We explain what drives the adjusted EBITDA multiple and what the pence-per-item benchmark reflects, so buyers and sellers can interrogate a broker's number rather than just accept it. We use the purchase affordability calculator to let you model the arithmetic against your own inputs, not an asserted market figure.
Purchase price allocation for tax and accounting
Once a price is agreed, it must be allocated across goodwill, stock, fixtures, and property. Each has a different tax treatment, and the allocation affects the buyer's post-acquisition tax profile and the seller's gain computation. We advise on a defensible allocation that both sides can support.
Valuation support for transactions, disputes, and planning
We support buyers and sellers through the valuation mechanics at key moments: pre-sale planning, buyer due diligence, partner exit, probate, and divorce. Where a dispute requires an independent view of the method and the inputs, we can provide it within our accounting and tax advisory scope.
Common questions
Community pharmacies are valued primarily on a multiple of adjusted EBITDA, with pence-per-item benchmarks used alongside by specialist brokers. Goodwill, driven by the NHS contract and prescription volume, dominates the price. The adjusted EBITDA normalises for owner pay, one-offs, and Drug Tariff margin volatility. We do not assert a specific multiple without a cited market source, because the right multiple depends on the contract profile, location, competition, and current market conditions.
The value of a community pharmacy is largely in its NHS contract, not its physical assets. The contract determines the item volume and the reimbursement income, and market entry for pharmacies in England is regulated under the 2013 Regulations, so the contract cannot simply be replicated by opening a new pharmacy. The scarcity of the contract right is what drives goodwill to dominate the price.
We explain the adjusted EBITDA and pence-per-item methods and let you model the arithmetic with your own inputs using the purchase affordability calculator. We do not assert a specific multiple without a cited market source captured at the time: an invented figure is the most damaging thing we could give a buyer or seller. If you need a current market-referenced multiple, speak to us and we will advise on what a specialist pharmacy broker publication currently supports.
On a company purchase, corporation tax relief on purchased goodwill is restricted and only available in limited cases at fixed rates under HMRC's rules: for a business bought on or after 1 April 2019, the company has to acquire qualifying IP assets with it, and relief is then a fixed 6.5% a year on goodwill of no more than six times the IP's cost. It is not generally available in the way plant-and-machinery allowances are. The position depends on the deal structure and the nature of the goodwill. We assess it before completion, not after the price is locked in.
Speak to a pharmacy finance specialist.
Tell us about your situation and we will reply within 24 hours.